S066-0293 Screening compound: 4-(6-{[1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy}pyrimidin-4-yl)morpholine

S066-0293 Screening compound: 4-(6-{[1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy}pyrimidin-4-yl)morpholine
S066-0293 Screening compound: 4-(6-{[1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy}pyrimidin-4-yl)morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound S066-0293
4-(6-{[1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy}pyrimidin-4-yl)morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S066-0293

Molecular Formula

C18H21N5O3 (C18 H21 N5 O3)

Compound Name

4-(6-{[1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy}pyrimidin-4-yl)morpholine

IUPAC name

4-(6-{[1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy}pyrimidin-4-yl)morpholine

SMILES

O=C(c1ccncc1)N(CC1)CC1Oc1ncnc(N2CCOCC2)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

355.4

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.786

Distribution Coefficient, logD

0.784

Water Solubility, LogSw

-0.97

Polar Surface Area

63.411

Acid Dissociation Constant (pKa)

23.11

Base Dissociation Constant (pKb)

5.14

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.40

S066-0293 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S066-0293 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S066-0293?
Check Price and Availability of S066-0293, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S066-0293 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S066-0293
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S066-0293
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S066-0293 available by request